It is already known that TG2 inhibits PTEN, a negative regulator of the PI3K-Akt signaling pathway, leading to the activation of this pathway in acute promyelocytic leukemia cells and pancreatic cancer cells [23,24]. This evidence concerns the gene TGM2 and familial pancreatic carcinoma.